06
Mar
Which Company Is Working On Covid 19 Vaccine In India. Though Kang named six companies the WHO has listed only Zydus Cadila and Serum Institute from India as among the global firms working on a COVID-19 vaccine. On Friday the White House announced an agreement to bolster Indias COVID-19 vaccine production by another billion doses. The companies plan to start a Phase 3 study in the coming weeks and aim to have results by the fourth quarter. SII is the largest manufacturer of vaccines in the world and can produce 70 million doses of the vaccine per month.
Though Kang named six companies the WHO has listed only Zydus Cadila and Serum Institute from India as among the global firms working on a COVID-19 vaccine. The companies plan to start a Phase 3 study in the coming weeks and aim to have results by the fourth quarter. Hyderabad-based biopharma company Biological E Limited is also working on a vaccine candidate for COVID-19. A total of three manufacturers are conducting human trials of Covid-19 in the country which include the Serum Institute of India Cadila Healthcare and Bharat Biotech International Limited. There are no licensed vaccines or therapeutics for this novel coronavirus now referred to as COVID-19. Importantly the vaccines safety profile appeared to be better than the previous version.
But India needs at least 170 million doses monthly in order to vaccinate 80 of.
Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end. There are no licensed vaccines or therapeutics for this novel coronavirus now referred to as COVID-19. Bharat Biotech Serum Institute Zydus Cadila Panacea Biotec Indian Immunologicals Mynvax and Biological E are among the domestic pharma firms working on Covid-19 vaccines in India. Importantly the vaccines safety profile appeared to be better than the previous version. The companies plan to start a Phase 3 study in the coming weeks and aim to have results by the fourth quarter. SII is the largest manufacturer of vaccines in the world and can produce 70 million doses of the vaccine per month.